Medicine and Dentistry
Patient
100%
Prostate Cancer
39%
Therapeutic Procedure
37%
Combination Therapy
22%
Neoplasm
21%
Diseases
20%
Malignant Neoplasm
19%
Transplantation
18%
Breast Cancer
18%
Inpatient
17%
Cell Transplantation
16%
Hematopoietic Cell
16%
Man
15%
Overall Survival
14%
Survival
14%
Mortality
13%
Age
13%
Diagnosis
11%
Progression Free Survival
10%
Analysis
9%
Symptom
8%
Cells
8%
Screening
8%
Surgery
8%
Prostate Specific Antigen
7%
Woman
7%
Multiple Myeloma
7%
Carcinoma
6%
Incidence
6%
Myelofibrosis
6%
Follow up
6%
Blood
6%
Development
6%
Biopsy
6%
Chemotherapy
6%
Pilus
6%
Cancer Prevention
6%
Complication
6%
Arm
5%
Radiation Therapy
5%
Association
5%
Recurrent Disease
5%
Evaluation Study
5%
Prostatectomy
5%
Chemoprophylaxis
5%
COVID-19
5%
Toxicity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
17%
Malignant Neoplasm
11%
Breast Cancer
10%
Diseases
10%
Toxicity
8%
Clinical Trial
7%
Prostate Cancer
7%
Survival
6%
Myelofibrosis
5%
Overall Survival
5%
Multiple Myeloma
5%
Solid Malignant Neoplasm
5%
Drug
5%
Adverse Event
5%
Nursing and Health Professions
Patient
24%
Prostate Cancer
6%
Transplantation
5%